September
Midlands NHS Review: In conversation with Scott McKenzie
Mid-year insight into NHS priorities, pressures and opportunities across the Midlands
Join Scott McKenzie for a timely review of how NHS systems across the Midlands are evolving in 2026. Gain practical insight into regional priorities, system pressures and where Life Sciences teams can support meaningful change.
How HCPs Are Using AI When Making Prescribing Decisions
Discover how AI is transforming prescribing decisions – and future-proof your strategy
How are HCPs using AI to inform prescribing decisions – and what does that mean for Life Sciences? Mercede Pannozzo explores how generative AI is reshaping information access, trust and clinical decision-making. Gain practical insights to strengthen your AI literacy and stay relevant in a changing landscape.
The Drug Tariff Unpacked, Explained and Demystified
Decode primary care reimbursement and strengthen your NHS commercial strategy
With a primary care market worth billions of pounds annually in England alone, knowledge of the Drug Tariff and the Dictionary of Medicines and Devices (dm+d) is critical for commercial success.
Pharma: Achieving relevancy and true partnership with the NHS
Moving beyond intent to build meaningful, sustainable NHS partnerships
What does true partnership with the NHS really look like today? Join David Thorne to explore how pharma can stay relevant, navigate system complexity and build relationships that deliver real value.
The Left Shift with Scott McKenzie
Why NHS care is moving beyond hospitals – and what it means for Life Sciences engagement
The NHS is accelerating the shift of care into community and neighbourhood settings. Join Scott McKenzie to understand what this means for pharma, medtech and device companies, and how to adapt your strategy to stay relevant.